New Hope in Pancreatic Cancer Treatment: mRNA Vaccine Insights from Rambam Expert

Can mRNA Vaccines Help Fight Pancreatic Cancer? A Rambam Expert’s Perspective

Historically, pancreatic cancer is one of the deadliest malignancies. New data from the six-year follow-up of a clinical trial using a personalized mRNA vaccine offers a measure of hope. Irit Ben-Aharon, a world-renowned oncologist at Rambam Health Care Campus, comments on these findings.

Often diagnosed at an advanced stage, pancreatic cancer has a five-year survival rate of less than 13%. No routine screening test exists for early detection, and only about 20% of patients are eligible for surgery—a prerequisite for participation in this type of clinical trial.

Read more here: https://www.facebook.com/share/p/1RHGwMi8aH/

#cancerresearch #mRNAvaccines #pancreaticcancer #oncology #medicalinnovation